Mark Watson, MD, PhD

Medical School Department Pathology and Immunology
Mark Watson

Researcher Background

Primary Academic Title

Professor of Pathology and Immunology, Division of Clinical Pathology, Washington University School of Medicine

Education

  • 1992: MD/PhD, neuroscience, Washington University, St. Louis, MO

Research & Selected Publications

Research Interest

Identification and characterization of novel gene transcripts associated with breast cancer progression; expression fingerprinting of primary human breast tumors. Key words: Breast cancer, secretoglobins, gene expression profiling DNA microarrays, gene expression, molecular diagnostics.

In2O3 Nanoribbon-Based Field-Effect Transistor Biosensors for Ultrasensitive Detection of Exosomal Circulating microRNA with Peptide Nucleic Acid Probes.
Authors:

Zhao Z, Mallon K, Chen M, one or more additional authors omitted Watson MA, one or more additional authors omitted Zhou C

Journal & Year:

ACS Nano • 2025

Adjuvant Dose-Dense Chemotherapy in Hormone Receptor-Positive Breast Cancer.
Authors:

Metzger Filho O, Ballman K, Campbell J, one or more additional authors omitted Watson M, one or more additional authors omitted Symmans WF

Journal & Year:

J Clin Oncol • 2025

Active Monitoring With or Without Endocrine Therapy for Low-Risk Ductal Carcinoma In Situ: The COMET Randomized Clinical Trial.
Authors:

Hwang ES, Hyslop T, Lynch T, one or more additional authors omitted Watson MA, one or more additional authors omitted Partridge AH

Journal & Year:

JAMA • 2025

Endocrine-Sensitive Disease Rate in Postmenopausal Patients With Estrogen Receptor-Rich/ERBB2-Negative Breast Cancer Receiving Neoadjuvant Anastrozole, Fulvestrant, or Their Combin…
Authors:

Ma CX, Suman VJ, Sanati S, one or more additional authors omitted Watson MA, one or more additional authors omitted Carey LA

Journal & Year:

JAMA Oncol • 2024

Extrinsic and intrinsic preanalytical variables affecting liquid biopsy in cancer.
Authors:

Batool SM, Hsia T, Beecroft A, one or more additional authors omitted Watson M, one or more additional authors omitted Balaj L

Journal & Year:

Cell Rep Med • 2023

The Liquid Biopsy Consortium: Challenges and opportunities for early cancer detection and monitoring.
Authors:

Batool SM, Yekula A, Khanna P, one or more additional authors omitted Watson M, one or more additional authors omitted Balaj L

Journal & Year:

Cell Rep Med • 2023